Related Experiment Videos
Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically
1Schering-Plough Research Institute, Department of Central Nervous System/Cardiovascular Research, San Raffaele Science Park, Milan, Italy. mariagrazia.grilli@spcorp.com
Summary
Familial Alzheimer's Disease-linked Presenilin 1 (PS1) mutations increase neuronal vulnerability to excitotoxicity. Reducing PS1 expression offers neuroprotection, suggesting a therapeutic target for neurodegenerative diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Familial Alzheimer's Disease (FAD) is linked to Presenilin 1 (PS1) mutations.
- The direct role of FAD-associated PS1 mutations in neuronal vulnerability is debated.
- Excitotoxicity is a key factor in neuronal damage.
Purpose of the Study:
- To investigate the role of PS1 mutations in neuronal vulnerability to excitotoxicity.
- To determine if reduced PS1 expression confers neuroprotection.
Main Methods:
- Primary neurons from transgenic mice (mutated PS1, wild-type PS1, PS1 knockout) and antisense-treated wild-type mice were used.
- In vitro neurotoxicity models (excitotoxicity, hypoxic-hypoglycemic) were employed.
- In vivo models (kainic acid-induced excitotoxicity, middle cerebral artery occlusion) were utilized.
Main Results:
- Neurons overexpressing mutated PS1 showed increased vulnerability to excitotoxic and hypoxic-hypoglycemic damage.
- Reduced excitotoxic damage was observed in neurons with diminished or absent PS1 expression.
- In vivo studies showed accelerated hippocampal neuronal death in mice with mutated PS1 after kainic acid administration.
Conclusions:
- FAD-linked PS1 variants enhance neuronal vulnerability to excitotoxicity-related damage.
- Reducing endogenous PS1 expression provides neuroprotection.
- Targeting PS1 may offer a therapeutic strategy for neurodegenerative conditions involving excitotoxicity.